C46H62N8O8
Neat
855.05
1541171-68-9; Carfilzomib Impurity X; Carfilzomib Impurity 64; SCHEMBL16479300; (S)-N-((S)-1-(((2R, 4S)-1-((1H-benzo[d][1, 2, 3]triazol-1-yl)oxy)-2-hydroxy-2 and 6-dimethyl-3-oxoheptan-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide
(2S)-N-[(2S)-1-[[(2R, 4S)-1-(benzotriazol-1-yloxy)-2-hydroxy-2 and 6-dimethyl-3-oxoheptan-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide
InChI=1S/C46H62N8O8/c1-31(2)26-37(42(56)46(5,60)30-62-54-40-19-13-12-18-35(40)51-52-54)48-45(59)39(28-34-16-10-7-11-17-34)50-44(58)38(27-32(3)4)49-43(57)36(21-20-33-14-8-6-9-15-33)47-41(55)29-53-22-24-61-25-23-53/h6-19,31-32,36-39,60H,20-30H2,1-5H3,(H,47,55)(H,48,59)(H,49,57)(H,50,58)/t36-,37-,38-,39-,46+/m0/s1